Characteristics of 28 day deceased and survivors after an acute myocardial infarction in the REGICOR Study (Gerona, Spain, 1993–96)
| Deceased n=50 | Survivors n=612 | p Value | |
|---|---|---|---|
| n, Number of patients; NS, non-statistically significant; APE, acute pulmonary oedema. *Mean (SD). | |||
| †Occurrence of ventricular fibrillation or sustained ventricular tachycardia requiring immediate medical intervention during the acute phase of myocardial infarction within 72 hours of myocardial infarction onset. | |||
| Age* | 63.1 (10.4) | 61.0 (10.3) | NS |
| Women | 28.0% | 17.8% | 0.075 |
| Hypertension | 44.9% | 46.4% | NS |
| Diabetes | 50.0% | 28.9% | 0.002 |
| Smoking | 29.2% | 46.4% | 0.021 |
| Glycaemia >6.67 mmol/l on admission | 94.0% | 67.0% | <0.001 |
| Four day mean glycaemia >6.67 mmol/l | 89.2% | 58.0% | <0.001 |
| History of angina | 60.0% | 48.9% | 0.132 |
| Previous myocardial infarction | 4.0% | 2.5% | NS |
| History of heart failure | 28.0% | 9.2% | <0.0001 |
| Post myocardial infarction angina | 17.4% | 26.0% | NS |
| Arrhythmias† | 52.1% | 19.6% | <0.0001 |
| Anterior myocardial infarction | 59.5% | 32.5% | 0.001 |
| Non-Q wave myocardial infarction | 16.7% | 18.4% | NS |
| APE or cardiogenic shock | 71.4% | 9.7% | <0.001 |
| 28 day re-infarction | 4.2% | 2.6% | NS |
| Therapeutic and diagnostic procedures | |||
| Thrombolysis | 14.0% | 38.9% | <0.001 |
| Antiplatelet drugs | 86.0% | 97.9% | <0.001 |
| 28 day coronary angiograms | 8.2% | 18.8% | 0.062 |